Riskpilot← Back to searchSign inGet full accessGenax Aktiebolag
ABActiveOrg 5563159812Furumovägen 26 AGeneral medical practice activities · NACE 8621Est. 19881 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
66.5%
Financial strength
Net profit 2025
SEK 770K
1 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -57K | — |
| Net profit | SEK 770K | — |
| Total assets | SEK 6,4M | — |
| Equity | SEK 4,2M | — |
| Employees | 1 | — |
Legal name
Genax Aktiebolag
Org number
5563159812
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 januari 1988
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska förvalta värdepapper samt, i mindre omfattning, bedriva fritidspraktik med konsulttjänster inom medicinsk och ortopedkirurgisk verksamhet och därmed förenlig verksamhet.
Address
Furumovägen 26 A
Email
lennarthovelius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 4 | — | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −36 | −44 | −51 | 0 | −57 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | −36 | −44 | −51 | 0 | −57 |
| Net financials | 515 | 727 | 626 | — | 1 027 |
| Profit before tax | 480 | 682 | 574 | 0 | 970 |
| Tax | −102 | −140 | −118 | — | −200 |
| Net profit | 378 | 542 | 456 | — | 770 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 510 | 5 042 | 5 301 | — | 6 377 |
| Equity | 3 630 | 3 773 | 3 829 | — | 4 241 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 880 | 1 269 | 1 472 | — | 2 135 |
| Total debt | 880 | 1 269 | 1 472 | — | 2 135 |
EBITDA margin
-5700000.0%
This company
15.8%
Market median
-36076049% vs market
20212025
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20212025
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
20212025
Net profit margin
77000000.0%
This company
8.1%
Market median
+950617184% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Genax Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bojan Inga-Lill Hovelius | Deputy Board Member | 0 companies |
| Karl Lennart Hovelius | Board of Directors | 0 companies |